everi
year
mio
hepat
e
viru
hev
infect
death
associ
hev
worldwid
present
exist
specif
therapi
hev
natur
compound
silvestrol
potent
antivir
effect
strand
rnaviru
ebola
viru
also
strand
rna
virus
corona
picorna
zika
viru
inhibitori
effect
viru
spread
due
inhibit
deadbox
rna
helicas
requir
unwind
structur
untransl
region
utr
lead
impair
translat
viral
rna
hev
strand
rna
genom
contain
cap
short
utr
studi
aim
analyz
impact
silvestrol
hev
life
cycl
persist
infect
cell
instrument
studi
identifi
silvestrol
potent
inhibitor
releas
hev
infecti
viral
particl
goe
along
strongli
reduc
hev
capsid
protein
translat
retent
viral
rna
insid
cytoplasm
without
major
cytotox
effect
interestingli
parallel
silvestrol
affect
activ
antivir
major
vault
protein
mvp
transloc
cytoplasm
perinuclear
membran
data
character
complex
antivir
activ
silvestrol
show
silvestrol
broad
spectrum
function
sinc
hev
viru
without
complex
secondari
structur
genom
still
affect
infect
also
patient
need
bloodtransfus
clinic
cours
hepat
develop
upon
hev
infect
bear
mortal
rate
healthi
adult
wherea
fatal
increas
pregnant
women
infect
genotyp
chronic
hev
infect
may
develop
liver
cirrhosi
increasingli
recogn
immunosuppress
transplant
patient
hev
classifi
strand
ssrna
viru
member
hepevirida
famili
four
major
humanpathogen
genotyp
identifi
genotyp
restrict
human
wherea
genotyp
abl
infect
human
swine
genotyp
contain
kb
genom
compos
three
open
read
frame
orf
encod
nonstructur
polyprotein
mainli
respons
effici
viru
replic
encod
capsidform
core
protein
code
region
protein
unknown
function
hev
polyprotein
found
viru
proteom
compos
four
differ
subdomain
methyltransferas
domain
papainlik
cystein
proteas
domain
rna
helicas
domain
rna
depend
rna
polymeras
domain
indic
homolog
analys
evid
polyprotein
process
cleav
smaller
protein
cystein
proteas
fragment
show
propos
catalyt
activ
viral
rna
genom
contain
cap
short
utr
base
pair
indic
depend
caprecogn
protein
possibl
regul
base
untransl
region
sinc
genom
serv
templat
protein
biosynthesi
moreov
poli
adenyl
found
viru
genom
addit
studi
hev
genom
show
full
genom
serv
sole
templat
viral
protein
synthesi
also
bicistron
subgenom
rna
code
hev
egress
capsid
assembl
manag
via
exosom
pathway
import
interact
partner
tumor
suscept
gene
possibl
tether
capsid
endosom
sort
complex
requir
transport
escrt
mediat
entri
multivesicular
bodi
mvb
therefor
viral
particl
found
quasienvelop
particl
surround
exosom
membran
cell
cultur
supernat
patient
serum
excret
via
fece
nake
capsid
viral
particl
recent
form
describ
secret
homodim
addit
popul
found
assembl
capsid
silvestrol
cyclopenta
b
benzofuran
natur
compound
extract
plant
speci
aglaia
foveolata
compound
potent
select
inhibitor
eukaryot
initi
factor
rna
helicas
requir
unwind
rna
secondari
structur
utr
mrna
thu
creat
bind
platform
preiniti
complex
first
describ
growthinhibit
agent
human
breast
prostat
xenograft
model
inhibit
translat
initi
cap
mrna
extend
structur
utr
often
found
protooncogen
well
toler
mice
use
experi
furthermor
silvestrol
prolong
surviv
rate
mice
hepatocellular
cancer
therefor
discuss
potenti
novel
anticanc
drug
although
use
human
clinic
trial
far
recent
studi
publish
show
potent
antivir
effect
silvestrol
cell
infect
ebola
viru
strand
ssrna
viru
transcrib
genom
rna
cap
mrna
rel
long
structur
utr
seem
caus
compound
effect
exampl
rna
virus
affect
silvestrol
identifi
coronaviru
cov
human
rhinoviru
hrv
zika
viru
zikv
polioviru
type
pv
therefor
silvestrol
appear
interest
agent
test
strand
ssrna
viru
contain
short
utr
hev
cours
studi
major
vault
protein
mvp
discov
certain
import
context
hev
silvestrol
mvp
kda
cytosol
protein
describ
build
main
part
ribonucleoprotein
particl
call
vault
link
drugresist
sever
type
nonvir
diseas
well
virusmedi
pathogenesi
modul
innat
antivir
immunerespons
hepat
e
viru
first
discov
one
major
caus
acut
hepat
worldwid
often
spread
develop
countri
poor
hygien
standard
although
hepat
e
viru
hev
immun
respons
observ
world
especi
recent
year
sinc
case
studi
control
conduct
observ
hev
also
widespread
european
countri
america
sinc
topic
becom
awar
becam
obviou
hev
viru
consid
waterborn
also
foodborn
livestock
exampl
domest
pig
infect
zoonot
genotyp
make
possibl
conductor
transmitt
hev
infect
past
decad
new
infect
regist
europ
show
increas
number
case
meatconsum
custom
western
countri
risk
hev
gain
insight
effect
silvestrol
hev
life
cycl
persist
hevinfect
cell
line
use
specif
cell
line
infect
hev
isol
chronic
infect
patient
hev
genotyp
strain
show
longlast
hev
geneexpress
viral
particl
product
optim
experiment
usag
aim
studi
evalu
possibl
antivir
effect
silvestrol
hev
therebi
get
deeper
insight
viru
life
cycl
character
silvestrol
respect
antivir
activ
possibl
identifi
novel
hostfactor
import
context
hevinfect
besid
cell
german
collect
microorgan
cell
cutur
dsmz
acc
origin
human
lung
carcinoma
cell
repres
subclon
cell
atcc
show
increas
suscept
infect
hev
strain
genotyp
hev
genotyp
strain
origin
isol
chronic
infect
patient
cell
line
persist
infect
strain
gener
inocul
cell
viru
subsequ
cell
passag
cell
line
show
longterm
express
hev
protein
releas
infecti
viral
particl
cell
well
persist
hevinfect
cell
cultur
highglucos
gl
dulbecco
modifi
eagl
medium
dmem
biowest
franc
supplement
mm
lglutamin
streptomycin
uml
penicillin
paa
linz
austria
vv
fetal
bovin
serum
fb
superior
sigmaaldrich
hamburg
germani
cell
cultur
c
humidifi
atmospher
contain
co
cell
seed
polystyren
plate
plate
greiner
frickenhausen
germani
contain
cellswel
cellswel
respect
h
cultur
medium
exchang
medium
contain
nm
nm
silvestrol
origin
medchemexpress
llc
princeton
nj
usa
puriti
vv
dmso
genaxxon
biberach
germani
h
medium
either
exchang
fresh
treatment
medium
harvest
respect
time
point
cell
lyze
ripa
buffer
mm
tri
mm
nacl
wv
sd
wv
sodium
deoxychol
wv
triton
ph
sonic
boil
gel
load
buffer
wv
sd
mm
tri
vv
glycerol
vv
ph
buffer
sdspage
perform
describ
protein
separ
sdspage
blot
pvdfmembran
appli
current
macm
gel
use
semidri
blot
approach
describ
protein
interest
detect
specif
primari
antibodi
blot
rabbitantihev
capsid
protein
antiserum
kindli
provid
dr
rainer
ulrich
friedrichloefflerinstitut
feder
research
institut
anim
health
grifswald
germani
betaactin
detect
use
commerci
avail
monoclon
mous
antibodi
mous
anti
betaactin
ml
sigmaaldrich
hamburg
germani
mvp
detect
use
commerci
avail
monoclon
mous
antibodi
mous
anti
lrp
santacruz
biotechnolog
heidelberg
germani
gapdh
detect
polyclon
antiserum
rabbitanti
gapdh
santa
cruz
biotechnolog
heidelberg
germani
histon
detect
polyclon
rabbit
antiserum
rabbitantihiston
santa
cruz
biotechnolog
heidelberg
germani
secondari
antibodi
detect
perform
use
licor
odyssey
infrar
imag
bioscienc
lincoln
ne
usa
accord
manufactur
protocol
secondari
antibodi
obtain
licor
total
protein
stain
perform
use
ponceau
carl
roth
karlsruh
germani
cell
lyze
rna
extract
use
peqgold
trifast
peqlab
erlangen
germani
revers
transcript
extract
rna
perform
use
revertaid
h
minu
rt
thermoscientif
braunschweig
germani
rna
cell
cultur
supernat
purifi
use
qiamp
viral
rna
kit
qiagen
hilden
germani
procedur
perform
accord
manufactur
protocol
quantif
intracellular
viral
rna
perform
base
sybrgreen
system
use
maxima
sybrgreen
qpcr
kit
thermoscientif
braunschweig
germani
primer
flank
hev
fwd
ggt
ggt
ttc
tgg
ggt
rev
agg
ggt
tgg
ttg
gat
housekeep
gene
fwd
aaa
gct
gtc
atc
gtg
aag
aac
rev
gct
gct
act
ttg
cgg
ggg
order
abl
normal
intracellular
measur
sybrgreen
base
assay
use
experiment
setup
quantif
extracellular
viral
rna
perform
base
hydrolysisprob
system
use
lightcycl
multiplex
rna
master
mix
roch
diagnost
mannheim
germani
lightmix
modular
hepat
e
viru
kit
quantit
kit
tib
molbio
berlin
germani
light
mix
modular
hev
kit
ce
mark
base
real
time
pcr
kit
detect
limit
iuml
hev
genotyp
contain
hev
specif
primer
respect
hydrolysi
probe
procedur
perform
accord
manufactur
protocol
analyz
either
lightcycl
lightcycl
instrument
ii
roch
mannheim
germani
cell
seed
flatbottom
polystyren
plate
greiner
frickenhausen
germani
densiti
cellswel
five
hour
post
seed
cell
infect
supernat
harvest
h
h
h
begin
silvestrol
treatment
dilutionseri
use
rang
undilut
dilut
factor
step
fit
aim
end
point
dilut
assay
epda
infect
last
h
stop
medium
exchang
cell
cultur
h
post
infect
infect
evalu
via
immunofluoresc
tcid
valu
calcul
describ
cell
transfect
electropor
vitro
transcrib
hev
report
construct
bear
code
sequenc
secret
gaussia
luciferas
insert
hev
hev
genotyp
strain
kindli
provid
prof
suzann
emmerson
describ
previous
lysat
harvest
h
h
h
begin
silvestrol
treatment
monitor
luciferas
activ
use
gaussiajuic
kit
pjk
kleinbittersdorf
germani
accord
manufactur
protocol
chemiluminesc
measur
orion
ii
micropl
luminomet
titertek
pforzheim
de
germani
valu
normal
total
protein
amount
respect
cell
protein
amount
measur
use
bradford
assay
accord
manufactur
protocol
bradford
reagent
thermoscientif
braunschweig
germani
cell
seed
flatbottom
polystyren
plate
greiner
frickenhausen
germani
densiti
cellswel
viabil
monitor
h
h
h
cell
fix
ethanol
block
wv
bovin
serum
albumin
tbst
tri
buffer
salin
mm
tri
mm
sodium
chlorid
ph
supplement
vv
tween
incub
respect
primari
antibodi
monoclon
mouseantihev
capsid
protein
kindli
provid
prof
jihong
meng
monoclon
mouseantilrp
mvp
santacruz
biotechnolog
heidelberg
germani
primari
antibodi
epitop
detect
coupl
donkeyantimous
donkeyantirabbit
antibodi
invitrogen
carlsbad
ca
usa
nuclei
stain
ngml
dapi
secondari
antibodi
solut
microscopi
perform
use
nikon
tiu
microscop
nikon
metrolog
gmbh
alzenau
germani
imag
perform
use
mono
camera
nikon
metrolog
gmbh
alzenau
germani
confoc
microscopi
confoc
laser
scan
microscop
meta
carl
zeiss
ag
jena
germani
use
persist
hevinfect
cell
cell
cultur
h
presenc
absenc
nm
silvestrol
cell
harvest
homogen
pb
cytosol
protein
extract
sequenti
centrifug
beckmann
optima
ultracentrifug
beckmann
coulter
krefeld
germani
describ
previous
absenc
nuclear
protein
cytosol
fraction
test
western
blot
analysi
use
histon
studi
design
includ
three
treatment
replic
cell
type
everi
replic
subject
lcm
analysi
record
data
set
total
prior
insolut
digest
assay
protein
concentr
sampl
determin
bradford
assay
ten
microgram
total
solubl
protein
adjust
total
volum
mm
nh
hco
sampl
reduc
mm
dtt
mm
nh
hco
min
c
thermal
cycler
bibbi
scientif
staffordshir
uk
alkyl
mm
iodoacetamid
mm
nh
hco
min
ambient
temperatur
dark
sampl
digest
trypsin
proteas
protein
ratio
mm
nh
hco
incub
h
c
thermal
cycler
reaction
stop
addit
formic
acid
result
tryptic
digest
store
c
ms
analys
digest
sampl
spike
massprep
adh
digest
standard
water
manchest
uk
use
intern
standard
level
fmol
per
sampl
analysi
ng
digest
protein
aliquot
analyz
use
nanouplc
esi
qtofm
nanoacqu
uplc
mclass
system
synapt
ms
water
milford
ct
usa
equip
trap
column
acquiti
uplc
mclass
symmetri
trap
column
mm
water
milford
ct
usa
hss
analyt
column
nanoacqu
uplc
hss
column
mm
water
milford
ct
usa
ms
oper
posit
vmode
use
standard
paramet
lockmass
calibr
scan
everi
data
acquir
use
dataindepend
acquisit
udm
e
mode
alter
low
v
high
ramp
v
v
collis
energi
scan
time
data
acquir
mz
rang
raw
data
process
databas
search
databas
consist
unreview
uniprot
entri
virus
taxon
identifi
homo
sapien
bo
avail
august
protein
quantif
statist
evalu
semiquantit
protein
express
profil
perform
progenesi
qi
proteom
water
manchast
uk
statist
analys
anova
test
ms
data
perform
prism
graphpad
use
multipl
ttest
determin
pvalu
error
bar
display
valu
sem
singl
dataset
alway
refer
dmso
control
set
control
respect
subsequ
pool
yield
mean
valu
experi
one
kind
control
group
dmso
arbitrarili
set
standard
deviat
control
group
report
standard
measur
valu
rel
control
group
perform
independ
assay
therefor
measur
treatment
group
assay
depend
match
n
x
alway
display
number
separ
perform
independ
experi
studi
potenti
antivir
effect
silvestrol
hev
persist
hevinfect
cell
treat
silvestrol
number
releas
hev
genom
analyz
rtqpcr
silvestrol
concentr
nm
extracellular
rna
level
significantli
decreas
h
h
treatment
compar
dmso
howev
h
signific
reduct
viral
rna
cell
cultur
supernat
observ
contrast
cell
treat
nm
silvestrol
signific
chang
number
hevspecif
genom
observ
h
figur
nonetheless
h
h
robust
reduct
extracellular
hev
rna
fivefold
compar
dmso
found
virus
x
sem
singl
dataset
alway
refer
dmso
control
set
control
respect
subsequ
pool
yield
mean
valu
experi
one
kind
control
group
dmso
arbitrarili
set
standard
deviat
control
group
report
standard
measur
valu
rel
control
group
perform
independ
assay
therefor
measur
treatment
group
assay
depend
match
n
x
alway
display
number
separ
perform
independ
experi
studi
potenti
antivir
effect
silvestrol
hev
persist
hevinfect
cell
treat
silvestrol
number
releas
hev
genom
analyz
rtqpcr
silvestrol
concentr
nm
extracellular
rna
level
significantli
decreas
h
h
treatment
compar
dmso
howev
h
signific
reduct
viral
rna
cell
cultur
supernat
observ
contrast
cell
treat
nm
silvestrol
signific
chang
number
hevspecif
genom
observ
h
figur
nonetheless
h
h
robust
reduct
extracellular
hev
rna
fivefold
compar
dmso
found
quantif
viral
genom
directli
reflect
number
infecti
viral
particl
determin
perform
directli
quantifi
infecti
viral
particl
cell
cultur
supernat
cell
cultur
supernat
dmso
treat
cell
serv
control
viral
titer
cell
cultur
supernat
analyz
via
epda
subsequ
quantif
viral
genom
directli
reflect
number
infecti
viral
particl
determin
tcid
perform
directli
quantifi
infecti
viral
particl
cell
cultur
supernat
cell
cultur
supernat
dmso
treat
cell
serv
control
viral
titer
cell
cultur
supernat
analyz
via
epda
subsequ
tcid
determin
figur
show
absolut
valu
figur
show
rel
quantif
contrast
effect
amount
viral
rna
signific
reduct
releas
infecti
viral
particl
treatment
nm
nm
silvestrol
determin
time
point
decreas
rang
reduct
nm
reduct
nm
silvestrol
figur
c
case
decreas
becom
pronounc
increas
treatment
time
taken
togeth
data
indic
silvestrol
caus
signific
decreas
number
releas
infecti
viral
particl
exclud
observ
effect
silvestrol
hev
releas
due
cytotox
effect
redoxmetabol
activ
silvestroltr
cell
analyz
prestoblu
assay
cellular
integr
assess
ldh
assay
analyz
whether
hev
replic
sensit
cell
silvestrolmedi
toxic
effect
noninfect
cell
test
addit
figur
ldh
assay
nm
silvestrol
show
cellular
integr
stronger
affect
h
treatment
compar
incub
period
h
h
moreov
found
higher
concentr
nm
lead
increas
cell
death
investig
time
point
figur
b
time
point
chosen
concord
overal
experiment
setup
determin
figur
show
absolut
valu
figur
show
rel
quantif
contrast
effect
amount
viral
rna
signific
reduct
releas
infecti
viral
particl
treatment
nm
nm
silvestrol
determin
time
point
decreas
rang
reduct
nm
reduct
nm
silvestrol
figur
c
case
decreas
becom
pronounc
increas
treatment
time
taken
togeth
data
indic
silvestrol
caus
signific
decreas
number
releas
infecti
viral
particl
exclud
observ
effect
silvestrol
hev
releas
due
cytotox
effect
redoxmetabol
activ
silvestroltr
cell
analyz
prestoblu
assay
cellular
integr
assess
ldh
assay
analyz
whether
hev
replic
sensit
cell
silvestrolmedi
toxic
effect
noninfect
cell
test
addit
figur
ldh
assay
nm
silvestrol
show
cellular
integr
stronger
affect
h
treatment
compar
incub
period
h
h
moreov
found
higher
concentr
nm
lead
increas
cell
death
investig
time
point
figur
b
time
point
chosen
concord
overal
experiment
setup
reflect
prestoblu
assay
use
evalu
redoxmetabol
activ
figur
silvestrol
significantli
affect
redoxmetabol
activ
persist
hevinfect
cell
lower
concentr
nm
howev
nm
reduct
reflect
prestoblu
assay
use
evalu
redoxmetabol
activ
figur
silvestrol
significantli
affect
redoxmetabol
activ
persist
hevinfect
cell
lower
concentr
nm
howev
nm
reduct
observ
cell
line
figur
describ
reduc
redoxmetabol
activ
associ
significantli
elev
cell
death
shown
ldh
assay
figur
b
show
antivir
effect
silvestrol
nm
due
effect
cellular
integr
reflect
result
ldh
assay
next
set
experi
perform
monitor
effect
silvestrol
level
intracellular
hevspecif
rna
therefor
total
rna
extract
persist
hevinfect
cell
h
h
h
begin
silvestrol
treatment
analyz
qpcr
primer
use
experi
flank
region
viral
genom
therebi
quantifi
genom
subgenom
rna
qpcr
figur
reveal
treatment
silvestrol
concentr
nm
led
initi
increas
h
intracellular
hevspecif
rna
compar
control
signific
treat
cell
nm
silvestrol
show
signific
decreas
intracellular
amount
viral
rna
h
h
howev
h
intracellular
amount
hevspecif
rna
almost
unchang
compar
control
observ
cell
line
figur
describ
reduc
redoxmetabol
activ
associ
significantli
elev
cell
death
shown
ldh
assay
figur
b
show
antivir
effect
silvestrol
nm
due
effect
cellular
integr
reflect
result
ldh
assay
next
set
experi
perform
monitor
effect
silvestrol
level
intracellular
hevspecif
rna
therefor
total
rna
extract
persist
hevinfect
cell
h
h
h
begin
silvestrol
treatment
analyz
qpcr
primer
use
experi
flank
region
viral
genom
therebi
quantifi
genom
subgenom
rna
qpcr
figur
reveal
treatment
silvestrol
concentr
nm
led
initi
increas
h
intracellular
hevspecif
rna
compar
control
signific
treat
cell
nm
silvestrol
show
signific
decreas
intracellular
amount
viral
rna
h
h
howev
h
intracellular
amount
hevspecif
rna
almost
unchang
compar
control
figur
effect
silvestrol
intracellular
amount
hevspecif
rna
cell
persist
infect
hev
strain
qpcr
analysi
use
primer
total
rna
isol
cell
persist
infect
hev
data
normal
intracellular
rna
level
cell
treat
nm
nm
silvestrol
dmso
treatment
serv
control
n
p
taken
togeth
data
show
effect
silvestrol
intracellular
amount
hevspecif
rna
depend
appli
silvestrol
concentr
durat
treatment
might
reflect
overlap
effect
silvestrol
least
viral
rna
stabil
translat
viral
rna
viral
replic
viral
releas
increas
intracellular
hevrna
silvestroltr
persist
hevinfect
cell
might
sever
reason
one
hypothesi
due
impair
packag
viral
genom
capsid
fewer
particl
form
releas
lead
intracellular
accumul
viral
rna
experiment
control
hypothesi
amount
intracellular
capsid
protein
persist
hevinfect
cell
treat
silvestrol
differ
time
point
determin
western
blot
analys
figur
effect
silvestrol
intracellular
amount
hevspecif
rna
cell
persist
infect
hev
strain
qpcr
analysi
use
primer
total
rna
isol
cell
persist
infect
hev
data
normal
intracellular
rna
level
cell
treat
nm
nm
silvestrol
dmso
treatment
serv
control
n
p
taken
togeth
data
show
effect
silvestrol
intracellular
amount
hevspecif
rna
depend
appli
silvestrol
concentr
durat
treatment
might
reflect
overlap
effect
silvestrol
least
viral
rna
stabil
translat
viral
rna
viral
replic
viral
releas
increas
intracellular
hevrna
silvestroltr
persist
hevinfect
cell
might
sever
reason
one
hypothesi
due
impair
packag
viral
genom
capsid
fewer
particl
form
releas
lead
intracellular
accumul
viral
rna
experiment
control
hypothesi
amount
intracellular
capsid
protein
persist
hevinfect
cell
treat
silvestrol
differ
time
point
determin
western
blot
analys
figur
inde
decreas
intracellular
amount
hev
capsid
protein
level
observ
nm
silvestrol
treatment
h
h
h
nm
h
treatment
figur
confirm
quantit
immunofluoresc
microscopi
silvestroltr
persist
hevinfect
cell
use
capsid
proteinspecif
antiserum
figur
compar
respect
quantif
dmso
control
figur
c
fluoresc
intens
hev
capsid
protein
express
cell
decreas
time
concentr
nm
nm
silvestrol
compar
control
figur
proport
hevposit
cell
reduct
observ
cell
grown
presenc
nm
silvestrol
figur
inde
decreas
intracellular
amount
hev
capsid
protein
level
observ
nm
silvestrol
treatment
h
h
h
nm
h
treatment
figur
confirm
quantit
immunofluoresc
microscopi
silvestroltr
persist
hevinfect
cell
use
capsid
proteinspecif
antiserum
figur
compar
respect
quantif
dmso
control
figur
c
fluoresc
intens
hev
capsid
protein
express
cell
decreas
time
concentr
nm
nm
silvestrol
compar
control
figur
proport
hevposit
cell
reduct
observ
cell
grown
presenc
nm
silvestrol
figur
persist
hevinfect
cell
use
capsid
proteinspecif
antiserum
figur
compar
respect
quantif
dmso
control
figur
c
fluoresc
intens
hev
capsid
protein
express
cell
decreas
time
concentr
nm
nm
silvestrol
compar
control
figur
proport
hevposit
cell
reduct
observ
cell
grown
presenc
nm
silvestrol
figur
data
indic
treatment
hevrepl
cell
nm
nm
silvestrol
lead
decreas
intracellular
amount
hev
capsid
protein
reduc
number
hevinfect
cell
experi
describ
figur
show
treatment
hevrepl
cell
lower
concentr
silvestrol
nm
lead
increas
intracellular
hevspecif
transcript
h
h
although
amount
releas
infecti
viral
particl
significantli
reduc
sever
reason
impair
releas
decreas
degrad
increas
replic
caus
elev
amount
hevspecif
transcript
investig
whether
silvestrol
addit
affect
viral
genom
replic
directli
report
genom
use
exclud
potenti
interfer
silvestrol
releas
gaussia
luciferas
gluc
affect
result
luciferas
activ
determin
cellular
lysat
measur
luciferas
activ
silvestrol
treatment
h
h
h
reveal
increas
genom
replic
could
observ
appli
silvestrol
concentr
evidenc
decreas
luciferas
activ
compar
control
rather
opposit
case
lower
concentr
nm
silvestrol
initi
inhibitori
effect
viral
replic
disappear
treatment
h
contrast
nm
silvestrol
h
almost
effect
observ
h
h
signific
reduct
found
data
argu
hypothesi
elev
level
hevspecif
rna
observ
treatment
lower
concentr
silvestrol
due
posit
effect
silvestrol
hevrepl
figur
cellular
lysat
measur
luciferas
activ
silvestrol
treatment
h
h
h
reveal
increas
genom
replic
could
observ
appli
silvestrol
concentr
evidenc
decreas
luciferas
activ
compar
control
rather
opposit
case
lower
concentr
nm
silvestrol
initi
inhibitori
effect
viral
replic
disappear
treatment
h
contrast
nm
silvestrol
h
almost
effect
observ
h
h
signific
reduct
found
data
argu
hypothesi
elev
level
hevspecif
rna
observ
treatment
lower
concentr
silvestrol
due
posit
effect
silvestrol
hevrepl
figur
corrobor
hypothesi
elev
intracellular
level
hevspecif
rna
silvestroltr
cell
primarili
due
impair
viral
morphogenesisreleas
corrobor
hypothesi
elev
intracellular
level
hevspecif
rna
silvestroltr
cell
primarili
due
impair
viral
morphogenesisreleas
caus
stimulatori
effect
hev
genom
replic
sinc
inhibitori
effect
measur
indic
data
describ
silvestrol
inhibitori
effect
hev
life
cycl
besid
ask
whether
activ
antivir
mechan
affect
silvestrol
address
persist
hevinfect
cell
cultur
presenc
absenc
silvestrol
intermedi
concentr
silvestrol
nm
treatment
last
h
effect
hev
present
chosen
hypothes
could
due
decreas
antivir
activ
caus
silvestrol
treatment
cytosol
protein
extract
insolut
protein
digest
subsequ
lcm
use
udm
e
analysi
perform
identifi
antivir
hostfactor
inhibit
silvestrol
tabl
show
major
vault
protein
mvp
unambigu
identifi
sampl
proven
strongli
regul
hevposit
h
neg
cell
treat
untreat
cell
compar
figur
display
graphic
represent
data
depict
tabl
tabl
identif
quantif
mvp
udm
e
cytosol
protein
level
major
vault
protein
mvp
uniprot
access
number
number
tryptic
digest
identifi
ms
number
uniqu
peptid
identifi
ms
confid
score
list
column
nm
treat
nontreat
persist
hevinfect
cell
column
annot
pvalu
column
foldchang
column
row
untreat
vs
treat
row
infect
untreat
vs
infect
treat
row
untreat
vs
infect
untreat
row
treat
vs
infect
treat
n
protein
express
level
presenc
absenc
silvestrol
intermedi
concentr
silvestrol
nm
treatment
last
h
effect
hev
present
chosen
hypothes
could
due
decreas
antivir
activ
caus
silvestrol
treatment
cytosol
protein
extract
insolut
protein
digest
subsequ
lcm
use
udm
e
analysi
perform
identifi
antivir
hostfactor
inhibit
silvestrol
tabl
show
major
vault
protein
mvp
unambigu
identifi
sampl
proven
strongli
regul
hevposit
h
neg
cell
treat
untreat
cell
compar
figur
display
graphic
represent
data
depict
tabl
tabl
n
p
data
shown
tabl
figur
demonstr
amount
mvp
cytoplasm
untreat
persist
hevinfect
cell
signific
higher
compar
hevneg
untreat
control
case
silvestroltr
cell
howev
signific
reduct
mvp
cytoplasm
observ
hevposit
cell
h
lead
amount
mvp
compar
amount
silvestrol
treat
hevneg
cell
recent
studi
describ
hepat
c
viru
vesicular
stomat
viru
influenza
viru
induc
mvp
express
turn
mvp
affect
viral
replic
trigger
express
typei
ifn
western
blot
analysi
use
mvpspecif
antibodi
cellular
lysat
deriv
noninfect
cell
persist
hevinfect
cell
confirm
signific
higher
amount
mvp
hevposit
cell
figur
b
howev
western
blot
analys
total
cellular
lysat
deriv
silvestroltr
untreat
hevrepl
cell
show
moder
decreas
total
amount
mvp
figur
address
mvp
subcellular
local
silvestroltreat
immunofluoresc
stain
figur
subcellular
fraction
persist
hevinfect
cell
subsequ
western
blot
analysi
respect
quantif
perform
figur
h
includ
broader
rang
concentr
fraction
match
initi
experiment
setup
proof
lack
antivir
activ
nm
silvestroltreat
cours
h
depict
quantif
hev
capsid
protein
express
cell
treat
nontreat
hevinfect
cell
figur
well
repres
western
blot
respect
quantif
figur
j
higher
amount
mvp
hevposit
cell
figur
b
howev
western
blot
analys
total
cellular
lysat
deriv
silvestroltr
untreat
hevrepl
cell
show
moder
decreas
total
amount
mvp
figur
address
mvp
subcellular
local
silvestroltreat
immunofluoresc
stain
figur
subcellular
fraction
persist
hevinfect
cell
subsequ
western
blot
analysi
respect
quantif
perform
figur
h
includ
broader
rang
concentr
fraction
match
initi
experiment
setup
proof
lack
antivir
activ
nm
silvestroltreat
cours
h
depict
quantif
hev
capsid
protein
express
cell
treat
nontreat
hevinfect
cell
figur
well
repres
western
blot
respect
quantif
figur
j
first
glanc
result
display
figur
seem
contrast
data
obtain
ms
howev
consid
ms
data
indic
amount
cytoplasm
reduc
investig
confoc
immunofluoresc
microscopi
perform
confoc
immunofluoresc
microscopi
use
mvpspecif
antibodi
hevposit
hevneg
cell
subject
silvestrol
treatment
solv
seem
contradict
immunofluoresc
confirm
increas
amount
mvp
persist
hevinfect
cell
compar
hevneg
control
cell
immunofluoresc
microscopi
demonstr
hevposit
silvestroltr
cell
mvp
chang
subcellular
local
case
untreat
cell
cytoplasm
local
observ
case
silvestroltr
cell
mvp
display
perinuclear
dotlik
stain
figur
reflect
decreas
mvp
concentr
observ
mass
spectrometri
analysi
cytosol
fraction
primarili
due
transloc
cytoplasm
perinuclear
membran
minor
part
due
decreas
total
amount
addit
subcellular
fraction
experi
cell
treat
nm
nm
nm
h
perform
nuclear
lysat
cytoplasm
analyz
western
blot
use
mvpspecif
antibodi
figur
quantif
western
blot
figur
show
amount
mvp
cytoplasm
significantli
decreas
significantli
increas
nuclear
lysat
nm
accord
observ
withdraw
mvp
cytoplasm
result
loss
antivir
activ
cell
treat
nm
silvestrol
quantif
immunofluoresc
stain
corespecif
antiserum
figur
f
show
signific
reduct
number
hev
posit
cell
nm
silvestrol
stand
contrast
signific
reduct
observ
nm
nm
treat
cell
figur
c
also
confirm
western
blot
analysi
cellular
lysat
deriv
cell
treat
nm
silvestrol
h
h
h
use
core
specif
antiserum
contrast
observ
reduct
amount
intracellular
hev
capsid
protein
observ
cell
treat
nm
nm
silvestrol
figur
c
observ
cell
treat
nm
silvestrol
figur
j
data
demonstr
direct
antivir
effect
silvestrol
translat
viral
rna
embed
silvestroldepend
modul
antivir
activ
silvestrol
inhibit
eukaryot
initi
factor
thu
affect
protein
synthesi
mrna
hev
compris
cap
rna
structur
strand
ssrna
genom
bicistron
rna
subgenom
effect
silvestrol
hev
life
cycl
investig
antivir
effect
silvestrol
unpreced
recent
studi
inhibitori
effect
silvestrol
ebola
viru
ebov
picornacorona
zika
viru
observ
hev
present
result
show
signific
reduct
infecti
hev
particl
releas
cultur
supernat
persist
hevinfect
cell
upon
treatment
silvestrol
concentr
nm
nm
compar
amount
releas
viral
genom
number
infecti
viral
particl
show
initi
decreas
amount
releas
viral
genom
h
h
nm
silvestrol
disappear
h
contrast
number
releas
infecti
viral
particl
show
persist
reduct
time
sinc
mild
cytotox
effect
present
earli
time
point
treatment
silvestrol
concentr
nm
later
time
point
major
effect
viral
particl
hevcarri
exosom
releas
take
place
effect
due
ruptur
cell
may
caus
extracellular
vesicl
releas
cell
therebi
releas
partial
unspecif
intracellular
compon
protein
rna
extracellular
space
seen
sever
studi
report
releas
eg
hepat
c
viru
hcv
rna
cell
cultur
medium
via
exosom
nm
silvestrol
strong
inhibit
hev
life
cycl
observ
reflect
strong
decreas
number
releas
infecti
viral
particl
immunofluoresc
microscopi
show
less
hevposit
cell
reflect
impair
spread
hev
due
reduc
number
infecti
particl
hevposit
cell
show
strongli
reduc
capsid
proteinspecif
signal
reflect
impact
translat
viral
protein
recent
studi
highlight
three
form
hev
capsid
protein
present
infect
cell
part
differ
stage
viru
life
cycl
observ
overal
decreas
signal
western
blot
analys
lead
compar
reduct
form
respect
sinc
hev
genom
replic
significantli
inhibit
silvestrol
cours
h
highlight
compound
mainli
trigger
structur
protein
biosynthesi
therebi
hinder
capsid
format
viral
particl
releas
rather
inhibit
synthesi
viral
genom
progeni
viabil
assay
show
decreas
redoxmetabol
nm
factor
howev
compar
effect
amount
releas
viral
particl
factor
effect
redoxmetabol
much
smaller
effect
hev
signific
effect
cellular
integr
ldh
assay
confirm
specif
observ
effect
note
observ
effect
silvestrol
redoxmetabol
cell
observ
studi
partial
differ
previou
one
observ
cell
moreov
dapi
stain
show
format
fragment
nuclei
would
indic
apoptosi
observ
antivir
effect
silvestrol
seem
complex
one
hand
direct
effect
silvestrol
translat
viral
protein
reflect
decreas
amount
capsid
protein
hand
consid
silvestrol
inhibitor
also
affect
translat
activ
varieti
hostfactor
factor
could
includ
rnase
proteasom
lysosom
autophagosom
protein
activ
trigger
degrad
viral
genom
viral
protein
impair
stabil
ie
viral
genom
consequ
could
compens
inhibitori
effect
silvestrol
part
viral
life
cycl
context
hostfactor
may
play
crucial
role
normal
act
inhibitori
hev
natur
condit
mvp
identifi
hostfactor
strongli
upregul
hevposit
cell
describ
recent
hepat
c
viru
vesicular
stomat
viru
influenza
viru
induc
mvp
express
turn
mvp
affect
viral
replic
eg
trigger
express
typei
ifn
previou
studi
show
mvp
import
protein
regul
propag
innat
immunerespons
cellular
level
highlight
mvp
function
part
virusinduc
hostdefens
mechan
intermedi
concentr
silvestrol
nm
amount
mvp
hevposit
cell
moder
significantli
decreas
howev
subcellular
local
strongli
affect
silvestrol
lead
strong
decreas
mvp
level
cytosol
evidenc
mass
spectrometri
due
transloc
mvp
cytoplasm
perinuclear
region
shown
immunofluoresc
microscopi
set
observ
made
lcm
immunofluoresc
broader
context
prepar
nuclear
lysat
cytoplasm
cell
treat
nm
nm
nm
silvestrol
analyz
fraction
western
blot
use
mvpspecif
antibodi
dmso
treat
cell
serv
control
experi
confirm
mass
spectrometri
immunofluoresc
result
obtain
nm
data
show
signific
decreas
mvp
cytoplasm
signific
increas
mvp
nuclear
perinuclear
fraction
nm
compar
dmso
control
nm
nm
silvestrol
signific
chang
compar
dmso
control
transloc
prevent
mvp
fulfil
cytosol
signal
transduct
eg
induct
type
interferon
describ
part
antivir
respons
hcv
zikv
illustr
observ
effect
silvestrol
hev
life
cycl
reflect
overlap
effect
differ
kinet
silvestrol
hev
host
cellfactor
depend
concentr
silvestrol
durat
silvestrol
treatment
consid
silvestrol
novel
treatment
hev
infect
human
patient
research
need
done
field
furthermor
one
could
think
combin
treatment
silvestrol
eg
ribavirin
common
treatment
hevinfect
individu
sinc
case
viral
replic
well
viral
protein
translat
inhibit
studi
limit
genotyp
hev
strain
hev
genotyp
strain
may
use
check
genotyp
affect
silvestrol
well
elucid
whether
mvp
behav
similar
manner
herebi
true
broadspectrum
clinic
usag
compound
consid
studi
identifi
silvestrol
inhibitori
agent
hev
signific
reduct
viral
particl
releas
viral
protein
biosynthesi
furthermor
identifi
mvp
antivir
hostfactor
affect
natur
compound
lead
complex
interplay
direct
effect
viral
life
cycl
effect
antivir
activ
hostcel
consid
complex
interplay
silvestrol
action
hev
hostfactor
state
silvestrol
exert
strong
antivir
effect
hev
reflect
robust
reduct
amount
releas
viral
particl
hev
viru
short
utr
without
complex
secondari
rna
structur
data
provid
evid
broader
spectrum
silvestrol
antivir
usag
